CALT
Calliditas Therapeutics AB American Depositary Shares
CALT
CALT
Delisted
CALT was delisted on the 20th of September, 2024.
17 hedge funds and large institutions have $16.3M invested in Calliditas Therapeutics AB American Depositary Shares in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
90% less call options, than puts
Call options by funds: $50K | Put options by funds: $522K
Holders
17
Holding in Top 10
–
Calls
$50K
Puts
$522K
Top Buyers
| 1 | +$217K | |
| 2 | +$69.5K | |
| 3 | +$8.22K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$8.05K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$1.31K |
Top Sellers
| 1 | -$79K | |
| 2 | -$10.1K | |
| 3 | -$9.61K | |
| 4 |
Morgan Stanley
New York
|
-$5.99K |
| 5 |
JPMorgan Chase & Co
New York
|
-$3.32K |